Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...

Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...

In the first Untitled Letter issued by the FDA in 2026, BeOne Medicines was critiqued for a DTC TV ad promoting its BTK ...

Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter ...

NDLEA operatives have rearrested an 80-year-old ex-convict for drug trafficking and uncovered tramadol concealed in ...

In question is Esperion’s Lipid Lurkers educational campaign, which was launched in July 2024 with support from agency ...

Since the first chapter of the show, Chicago P.D. has seen great success. It has reached the thirteenth Season, with episode ...

As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them.

More than 500,000 Aussies are using GLP-1s like Ozempic and Mounjaro each month. The risks to people with eating disorders is ...

Trump said the Venezuelan president and his wife were "captured and flown out of the Country" to the U.S. following multiple ...

(AP) - U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, ...

Tony Dokoupil’s live CBS Evening News broadcast showcases the neon collection in Camp Washington after delivering the day’s ...